David Fabian
David Fabian (RSS)
FMD Capital Management

David currently is a Managing Partner at FMD Capital Management, a fee-only registered investment advisory firm specializing in exchange-traded funds. He has years of experience constructing actively managed growth and income portfolios using ETFs. David regularly contributes his views on wealth management in his company blog, podcasts, and special reports.

Read complete bio
Recent Articles

Don’t Mourn the Death of iShares’ Target-Date Funds

Aug. 21, 2014, 1:04 pm EDT – iShares is shutting down its target-date funds, but those types of funds aren't for savvy ETF investors, anyway. Retirement planners should look at these funds instead. More 

Why Is the SPY Overreacting to the Selloff?

Aug. 14, 2014, 11:15 am EDT – The SPY ETF still is the most popular way to get S&P 500 exposure, but its recent movement says a lot about who's actually buying it. More 

How to Pick the Best Retirement Funds

Aug. 14, 2014, 10:39 am EDT – If you're looking at retirement funds, should you put your faith in index funds or turn to active management for superior returns? More 

8 ETFs to Take Advantage of a Fed Stimulus Pullback

Aug. 1, 2014, 2:38 pm EDT – Interest rates could find renewed life, and if so, you'll want to be in the right position to profit. Try one or more of these ETFs. More 

3 Ways to Play Healthcare’s Hot Stocks

Jul. 24, 2014, 10:52 am EDT – Broad plays on healthcare stocks have done well historically, but investors can get some significant juice out of more targeted plays. More 

Don’t Sweat a Lack of ETF ‘Outperformance’

Jul. 16, 2014, 12:35 pm EDT – A recent article on ETF.com lamented the lack of alpha among ETF offerings ... but I think the author missed the point of exchange-traded vehicles. More 

Don’t Count on Dividend ETFs to Play Defense

Jul. 15, 2014, 9:42 am EDT – You should always have equity income in your portfolio, but don't think dividend ETFs will save you from a correction. They won't. More 

The Income Investor’s Guide to REIT ETFs

Jun. 30, 2014, 2:47 pm EDT – Real estate investment trusts and REIT ETFs have come a long way from the drubbing they experienced this time last year. Here are some of the big names you should know. More 

Biotech ETFs – Keep Those Buyouts Coming!

Jun. 12, 2014, 2:14 pm EDT – Merck's buyout of Idenix didn't just pump up IDIX shares -- it also had a great double effect on biotech ETFs such as XBI that usually are buoyed by M&A. More 

Don’t Complain About This Boring Market. Prepare.

Jun. 4, 2014, 5:48 am EDT – The slow but steady rise of the markets into the low-volume summer months is lulling many investors to sleep. But success favors the ready. More